Authors
Loading...
This analysis finds that plasma biomarkers enhance diagnostic accuracy for amyloid positivity in Alzheimer's disease, indicating their potential in clinical settings.
Chang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: